Related Experiment Video
Updated: Sep 18, 2025

A Method of Trigonometric Modelling of Seasonal Variation Demonstrated with Multiple Sclerosis Relapse Data
Published on: December 9, 2015
Comments on "Novel Non-Linear Models for Clinical Trial Analysis With Longitudinal Data: A Tutorial Using SAS for
M C Donohue1, P S Insel2, O Langford1
1Alzheimer's Therapeutic Research Institute, University of Southern California, San Diego, USA.
Nonlinear longitudinal models in clinical trials can be biased, inflating Type I errors and potentially masking treatment harm. Researchers must address these model limitations for accurate treatment effect estimation and patient safety.
Area of Science:
- Biostatistics
- Clinical Trial Design
- Longitudinal Data Analysis
Background:
- Nonlinear longitudinal proportional effect models are used in randomized clinical trials to estimate treatment effects.
- These models assume a constant proportional treatment effect over time.
Discussion:
- Violating the proportional effect assumption leads to bias and inflated Type I error rates.
- Even when the assumption holds, these models exhibit bias and are sensitive to treatment group labeling.
- Bias can favor the active treatment group, increasing false positives and potentially obscuring safety concerns.
Key Insights:
- The proportional effect assumption in nonlinear longitudinal models is often violated, causing significant statistical issues.
- Model bias can lead to incorrect conclusions about treatment efficacy and safety.
- Inference is compromised by sensitivity to treatment group labeling.
Outlook:
- Developing robust statistical models that do not rely on the proportional effect assumption is crucial.
- Further research is needed to correct bias and improve the reliability of treatment effect estimation in longitudinal studies.
- Addressing these limitations will enhance patient safety and the validity of clinical trial results.
Related Concept Videos
Statistical Software for Data Analysis and Clinical Trials
Parametric Survival Analysis: Weibull and Exponential Methods
Weibull Distribution
The Weibull distribution is a flexible model used in parametric survival analysis. It can handle both increasing and decreasing hazard rates, depending on its shape parameter...
Analysis Methods of Pharmacokinetic Data: Model and Model-Independent Approaches
The model approach uses mathematical models to describe changes in drug concentration over time. Pharmacokinetic models help characterize drug behavior in patients, predict drug concentration in the body fluids, calculate optimum dosage regimens, and evaluate the risk of toxicity. However, ensuring that the model fits the experimental data accurately...
Statistical Methods for Analyzing Epidemiological Data
Comparing the Survival Analysis of Two or More Groups
Introduction To Survival Analysis
The primary goal of survival analysis is to estimate survival time—the time...

